Published on 11 May 2022 on Zacks via Yahoo Finance
Here's Why You Should Hold on to CVS Health (CVS) For Now
CVS Health Corporation CVS has been gaining on strength across all operating segments. The company ended the first quarter of 2022 with better-than-expected results. The significant membership growth within the Health Care Benefits arm instills optimism. Robust front store sales also seem promising. However, tough competition and mounting expenses are discouraging.
Over the past year, the Zacks Rank #3 (Hold) stock has gained 17.7% compared with 4.7% growth of the industry and 1.7% fall of the S&P 500.
The renowned pharmacy innovation company has a market capitalization of $129.64 billion. Its earnings for first-quarter 2022 surpassed the Zacks Consensus Estimate by 3.7%.